A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum.

Lampertico, P

A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum. [electronic resource] - Hepatology (Baltimore, Md.) Dec 1997 - 1621-5 p. digital

Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

0270-9139

10.1002/hep.510260634 doi


Adult
Alanine Transaminase--blood
Biopsy
DNA, Viral--blood
Female
Follow-Up Studies
Hepatitis B Antibodies--analysis
Hepatitis B Surface Antigens--blood
Hepatitis B e Antigens--blood
Hepatitis B virus--genetics
Hepatitis B, Chronic--blood
Humans
Interferon alpha-2
Interferon-alpha--adverse effects
Liver--pathology
Male
Middle Aged
Prospective Studies
Recombinant Proteins